Potency of tenofovir in chronic hepatitis B: Mono or combination therapy?
- 1 March 2008
- journal article
- editorial
- Published by Elsevier in Journal of Hepatology
- Vol. 48 (3) , 383-386
- https://doi.org/10.1016/j.jhep.2007.12.006
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutationsJournal of Hepatology, 2008
- Antiviral drug-resistant HBVHepatology, 2007
- Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 YearsGastroenterology, 2006
- Intracellular Metabolism and In Vitro Activity of Tenofovir against Hepatitis B VirusAntimicrobial Agents and Chemotherapy, 2006
- Variant of Hepatitis B Virus with Primary Resistance to AdefovirNew England Journal of Medicine, 2006
- HBV drug resistance: Mechanisms, detection and interpretationJournal of Hepatology, 2006
- Virologic response and resistance to adefovir in patients with chronic hepatitis BJournal of Hepatology, 2005
- A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis BGastroenterology, 2005
- 36 Incidence and predictors of emergence of adefovir resistant HBV during four years of adefovir dipivoxil (ADV) therapy for patients with chronic hepatitis B (CHB)Journal of Hepatology, 2005
- Durability of Serologic Response After Lamivudine Treatment of Chronic Hepatitis BHepatology, 2003